The global kidney
function tests market is expected to reach USD 1.9 billion by
2025, according to a new study by Grand View Research, Inc. The growing
prevalence of Chronic Kidney Diseases (CKD) and renal failure is presumed to be
responsible for the high urgency to use kidney function tests, which is
anticipated tobroaden the scope for growth throughout the forecast period. In
addition, expanding base of diabetic population, which is highly susceptible to
the aforementioned diseases, is predicted to impel the demand further over the
coming years. Consequently, resultant high sample volume will require high
capability kidney function testing devices, which is believed to present the
market with significant growth potential opportunities.
In addition, growing awareness with respect to
diagnostic benefits associated with kidney function tests is also anticipated
to be one of the high impact rendering drivers for this market. Emergence of
technologically advanced products, such as automated analyzers, has led to
refinement of current real-time point-of-care testing capabilities and,
therefore, creates lucrative growth opportunities for the market. Furthermore,
presence of public as well private healthcare organizations consistently
striving to support diagnosis and management of CKD through a range of programs
and initiatives is expected to create potential demand.
Browse full research report on Kidney Function Tests Market: www.grandviewresearch.com/industry-analysis/kidney-function-tests-market
Further
key findings from the study suggest:
- Imaging tests are expected to exhibit lucrative CAGR owing to
increasing adoption in wide array of clinical applications. The high
penetration can be attributed to efficient renal function risk assessment
due to abnormal results generated through other tests
- Diagnostic laboratories are anticipated to exhibit lucrative CAGR
during the forecast period owing to increasing preference for
point-of-care testing by clinicians
- In 2016, North America held a dominant share of the global kidney
function tests market, as a consequence of increasing local presence of
prominent companies undertaking competitive sustainability strategies
- Asia Pacific is anticipated to grow at an exponential CAGR owing to
unmet needs of patients, continuous infrastructural & technological
upgradation, and increasing healthcare expenditure
- Some key participants such as Abbott Laboratories; Merck Millipore;
Alere, Inc.; and Quest Diagnostics are implementing various competitive
strategies, such as new product development & frequent product
approvals, to maintain their position in the market
- For instance, in March 2015, metropolis announced the launch of a
kidney function test, a PLA2R antibody test, that detects and evaluates
intensity of membranous nephropathy
Browse more reports of this category
by Grand View Research: www.grandviewresearch.com/industry/clinical-diagnostics
Grand
View Research has segmented the kidney function tests market on the basis of
product, end use, and region:
Kidney
Function Tests Product Outlook (Revenue, USD Million, 2014 - 2025)
- Dilution
& Concentration Tests
- Clearance
Tests
- Urine Tests
- Imaging Tests
Kidney
Function Tests End-Use Outlook (Revenue, USD Million, 2014 - 2025)
- Hospitals
- Diagnostic
Laboratories
- Academic
Research Laboratories
- Others
Kidney
Function Tests Regional Outlook (Revenue, USD Million, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- Asia Pacific
- Japan
- China
- India
- Latin America
- Mexico
- Brazil
- MEA
- South Africa
About Grand View
Research
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com
No comments:
Post a Comment